UBER
Lucid Stock is Sinking After It Disclosed a Big Earnings Miss
In filings related to a $1 billion capital raise, Lucid said that its first-quarter revenue will fall well below Wall Street expectations.
Motley Fool  ·  Apr 14, 2026 READ →
NVDA
Lucid Stock is Sinking After It Disclosed a Big Earnings Miss
In filings related to a $1 billion capital raise, Lucid said that its first-quarter revenue will fall well below Wall Street expectations.
Motley Fool  ·  Apr 14, 2026 READ →
INTC
Lucid Stock is Sinking After It Disclosed a Big Earnings Miss
In filings related to a $1 billion capital raise, Lucid said that its first-quarter revenue will fall well below Wall Street expectations.
Motley Fool  ·  Apr 14, 2026 READ →
INTC
Why Did Oklo Power Stock Pop Today?
Is good news for Rolls-Royce good news for Oklo, too?
Motley Fool  ·  Apr 14, 2026 READ →
NVDA
Why Did Oklo Power Stock Pop Today?
Is good news for Rolls-Royce good news for Oklo, too?
Motley Fool  ·  Apr 14, 2026 READ →
ORCL
Top Midday Gainers
Avanos Medical (AVNS) shares soared 70% amid heavy trading after the company said Tuesday it agreed
MT Newswires  ·  Apr 14, 2026 READ →
ABBV
Could AbbVie Crash Lilly's Weight‑Loss Party?
AbbVie is making progress in this market, but it is still far behind the leader.
Motley Fool  ·  Apr 14, 2026 READ →
INTC
Which Underperforming "Magnificent Seven" Stock Is the Better Buy in 2026: Tesla or Microsoft?
These stocks are both down more than 20% this year.
Motley Fool  ·  Apr 14, 2026 READ →
INTC
Could AbbVie Crash Lilly's Weight‑Loss Party?
AbbVie is making progress in this market, but it is still far behind the leader.
Motley Fool  ·  Apr 14, 2026 READ →
MSFT
Which Underperforming "Magnificent Seven" Stock Is the Better Buy in 2026: Tesla or Microsoft?
These stocks are both down more than 20% this year.
Motley Fool  ·  Apr 14, 2026 READ →
NVDA
Which Underperforming "Magnificent Seven" Stock Is the Better Buy in 2026: Tesla or Microsoft?
These stocks are both down more than 20% this year.
Motley Fool  ·  Apr 14, 2026 READ →
NVDA
Could AbbVie Crash Lilly's Weight‑Loss Party?
AbbVie is making progress in this market, but it is still far behind the leader.
Motley Fool  ·  Apr 14, 2026 READ →